What is the present valuation and projected CAGR of the cell dissociation market?
The cell dissociation market size has grown rapidly in recent years. It will grow from $0.38 $ billion in 2024 to $0.43 $ billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to increasing diabetes, rising prevalence of infectious diseases, rising animal-based elements, growing regenerative medicine, and rising cancer.
The cell dissociation market size is expected to see rapid growth in the next few years. It will grow to $0.69 $ billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing approval of cell-based research, increasing clinical trials, increasing biopharmaceutical and pharmaceutical companies, increasing incidence of chronic diseases, and increasing incidence of neurological disorders. Major trends in the forecast period include the development of patient-specific cell therapies, technological advancements, the introduction of fingerprint-based drug tests, the introduction of enzymatic cell dissociation methods, and the development of monoclonal antibodies.
Get Your Free Sample of The Global Cell Dissociation Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19360&type=smp
What key drivers have fueled the cell dissociation market’s development over the years?
The increasing incidence of chronic diseases is expected to propel the growth of the cell dissociation market going forward. The increasing incidence of chronic diseases is due to factors such as aging populations, lifestyle changes, and rising rates of obesity, physical inactivity, and unhealthy diets that contribute to the long-term development and persistence of conditions such as diabetes, heart disease, and cancer. Cell dissociation is crucial for studying chronic diseases as it enables researchers to isolate and analyze individual cells, aiding in the understanding of disease mechanisms and the development of targeted therapies. For instance, in August 2022, according to a report published by the American College of Cardiology, a US-based non-profit medical association, in the United States, it is projected that all four major cardiovascular risk factors will increase from 2025 to 2060. Diabetes is expected to see the largest percentage rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Additionally, significant increases in cardiovascular disease rates are anticipated for stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), with ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) following closely behind. Therefore, the increasing incidence of chronic diseases drives the cell dissociation market.
What is the segmentation for the cell dissociation market?
The cell dissociationmarket covered in this report is segmented –
1) By Product: Enzymatic Dissociation, Non-enzymatic Dissociation, Instruments And Accessories
2) By Tissue: Epithelial Tissue, Connective Tissue
3) By Application: Tissue Dissociation, Cell Detachment
4) By End-User: Pharmaceuticals And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CRO), Other End-Users
Subsegments:
1) By Enzymatic Dissociation: Trypsin Solutions, Collagenase Solutions, Dispase Solutions, Other Enzymatic Dissociation Reagents
2) By Non-Enzymatic Dissociation: Chemical Dissociation Solutions, Mechanical Dissociation Solutions, Hypotonic Solutions
3) By Instruments and Accessories: Cell Dissociation Systems, Tissue Homogenizers, Centrifuges, Cell Culture Plates And Flasks
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/cell-dissociation-global-market-report
Who are the most influential companies in the cell dissociation market?
Major companies operating in the cell dissociation market are Roche Holding AG, Danaher Corporation, Fujifilm Holdings Corporation, Becton Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group AG, Bio-Rad Laboratories Inc., Eppendorf AG, Bio-Techne Corporation, Miltenyi Biotec, BioLegend Inc., Cyagen Biosciences Inc., Cell Signaling Technology Inc., HiMedia Laboratories LLC, Gemini Bio-Products, Biological Industries USA Inc., BrainBits LLC, Biocompare Inc., AAT Bioquest Inc.
What are the top industry trends projected to impact the cell dissociation market?
Major companies operating in the cell dissociation market are focusing on developing technologically advanced products such as cell depletion and enrichment kits to gain a competitive advantage. These kits are designed to selectively deplete or enrich specific cell populations, improving the efficiency and accuracy of downstream applications in research and clinical settings. For instance, in February 2023, LevitasBio, a US-based biotechnology company, launched the LeviSelect Suite of Cell Depletion & Enrichment Kits. These kits offer unique features, including high-speed processing and minimal impact on cell viability, which enhance their utility in sensitive research environments. The LeviSelect kits also provide customizable protocols, allowing researchers to target a wide range of cell types with precision.
What are the major regional insights for the cell dissociation market, and which region holds the top position?
North America was the largest region in the cell dissociation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell dissociation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Cell Dissociation Market Report 2025 Offer?
The cell dissociation market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cell dissociation is the process of separating cells from tissues or cell cultures into a single-cell suspension. This process is achieved through enzymatic, mechanical, or chemical methods, ensuring that cells remain viable and functional for downstream applications. It is a crucial step in various research, diagnostic, and therapeutic procedures. Effective cell dissociation enables accurate analysis and utilization of individual cells in studies such as flow cytometry, cell culture, and single-cell sequencing.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19360
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
